Neumología
Specialty
Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Madrid, EspañaPublications in collaboration with researchers from Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (223)
2024
-
Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry
Archivos de Bronconeumologia, Vol. 60, Núm. 3, pp. 143-152
-
Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia
Scientific reports, Vol. 14, Núm. 1, pp. 12726
-
Clinical Presentation and Outcomes of Patients with Cancer-Associated Isolated Distal Deep Vein Thrombosis
Journal of Clinical Oncology, Vol. 42, Núm. 5, pp. 529-537
-
Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism
Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246
-
Effect of Obstructive Sleep Apnea during Pregnancy on Fetal Development: Gene Expression Profile of Cord Blood
International Journal of Molecular Sciences, Vol. 25, Núm. 10
-
Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients
ERJ Open Research, Vol. 10, Núm. 1
-
Influence of Clinical Practice Guidelines on the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis. Data from the Registry of the Spanish Society of Pulmonology and Thoracic Surgery
Open Respiratory Archives, Vol. 6, Núm. 3
-
Oxygen Therapy in Patients With Intermediate-Risk Acute Pulmonary Embolism: A Randomized Trial
Chest, Vol. 165, Núm. 3, pp. 673-681
-
Predictors of pulmonary embolism in chronic obstructive pulmonary diseases patients admitted for worsening respiratory symptoms: An individual participant data meta-analyses
European Journal of Internal Medicine
-
Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine
European Journal of Clinical Investigation
-
Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study
eClinicalMedicine, Vol. 73
-
The prognostic value of blood cellular indices in pulmonary embolism
American Journal of Hematology, Vol. 99, Núm. 9, pp. 1704-1711
-
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422
2023
-
A Study of the Prevalence of Asthma in the General Population in Spain
Open Respiratory Archives, Vol. 5, Núm. 2
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Early Desaturation During 6-Minute Walk Test is a Predictor of Mortality in COPD
Lung, Vol. 201, Núm. 2, pp. 217-224
-
Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease
Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565
-
Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study
Thrombosis Research, Vol. 228, pp. 1-9
-
First-Line Versus Second-Line Use of Reslizumab in Severe Uncontrolled Asthma
Journal of Investigational Allergology and Clinical Immunology
-
Highlights 56th SEPAR Congress
Open Respiratory Archives, Vol. 5, Núm. 3